Results 21 to 30 of about 11,770,891 (406)
Clinical Infectious Diseases, 2020 Nontuberculous mycobacteria (NTM) represent over 190 species and subspecies, some of which can produce disease in humans of all ages and can affect both pulmonary and extrapulmonary sites.
C. Daley +20 more
semanticscholar +1 more source
Journal of Thoracic Disease, 2021 Medication non-adherence to asthma and chronic obstructive pulmonary disease therapy poses a significant burden for patients and societies. Non-adherence encompasses poor initiation, implementation (including poor inhalation technique) and non ...
Evalyne M Jansen +5 more
semanticscholar +1 more source
A 73‐year‐old man with loss of consciousness during treatment for miliary tuberculosis
Respirology Case Reports, 2022 Key message Miliary tuberculosis is often associated with cerebral tuberculoma, which can manifest during treatment. We present images of a patient with cerebral tuberculoma detected due to emerging neurological symptoms during treatment of miliary ...
Masahiro Ohgiya +4 more
doaj +1 more source
BNP/NT-proBNP in pulmonary arterial hypertension: time for point-of-care testing?
European Respiratory Review, 2020 Despite the advent of new therapies and improved outcomes in patients with pulmonary arterial hypertension (PAH), it remains a life-shortening disease and the time to diagnosis remains unchanged.
Robert A. Lewis +3 more
doaj +1 more source
Inflammation to Pulmonary Diseases [PDF]
Mediators of Inflammation, 2016 Inflammation, which is induced and perpetuated by microorganism pathogens or from the damage or death of host cells, is an essential component of various common respiratory diseases, such as chronic obstructive pulmonary disease (COPD), asthma, bronchiectasis, and acute respiratory distress syndrome (ARDS), as well as of less common ones, for example ...
Kang-Yun Lee +2 more
openaire +3 more sources
Association between weight loss and mortality in idiopathic pulmonary fibrosis
Respiratory Research, 2022 Rationale Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive interstitial lung disease that has no cure. Many current research efforts center on diagnostic and therapeutic modalities for IPF while other risk factors affecting disease ...
Aleksandr Kalininskiy +5 more
doaj +1 more source
Implementing integrated care guidelines in asthma and COPD: It ain't easy!
Heliyon, 2023 Objective: To evaluate the implementation of a guideline-based, integrated, standardised, personal approach in patients with Chronic Obstructive Pulmonary Disease (COPD) or Asthma in a real-life situation.
Jan A. Witte +7 more
doaj +1 more source
Autophagy in Pulmonary Diseases [PDF]
American Journal of Respiratory and Critical Care Medicine, 2016 The pathogenesis of pulmonary diseases is often complex and characterized by multiple cellular events, including inflammation, cell death, and cell proliferation. The mechanisms by which these events are regulated in pulmonary diseases remain poorly understood.
Kiichi, Nakahira +2 more
openaire +2 more sources
Nature Communications, 2020 Chronic obstructive pulmonary disease (COPD) is the third commonest cause of death globally, and manifests as a progressive inflammatory lung disease with no curative treatment. The lung microbiome contributes to COPD progression, but the function of the
K. Bowerman +13 more
semanticscholar +1 more source
Bilateral diaphragmatic paralysis after kidney surgery
Monaldi Archives for Chest Disease, 2015 A 57-year-old woman underwent an enucleoresection of her right kidney angiomyolipoma. Two weeks later she was admitted to our hospital because of dyspnea at rest with orthopnea.
S. Sozzo +6 more
doaj +1 more source